KLK3 and benign prostatic hyperplasia: However, extensive data from the placebo arm of the Proscar Long-term Efficacy and Safety Study (PLESS) have demonstrated that PSA is a strong predictor of an enlarged prostate, or one that is likely to increase in size, as well as the risk of developing LUTS, poor urinary flow, AUR and/or BPH-related surgery (19).